{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:12:02Z","timestamp":1773378722626,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Key R&D Program of Jining","award":["No. 2023YXNS105"],"award-info":[{"award-number":["No. 2023YXNS105"]}]},{"name":"The Key R&D Program of Jining","award":["No. 2023YXNS105"],"award-info":[{"award-number":["No. 2023YXNS105"]}]},{"name":"The Key R&D Program of Jining","award":["No. 2023YXNS105"],"award-info":[{"award-number":["No. 2023YXNS105"]}]},{"name":"The Key R&D Program of Jining","award":["No. 2023YXNS105"],"award-info":[{"award-number":["No. 2023YXNS105"]}]},{"name":"The Key R&D Program of Jining","award":["No. 2023YXNS105"],"award-info":[{"award-number":["No. 2023YXNS105"]}]},{"name":"The Key R&D Program of Jining","award":["No. 2023YXNS105"],"award-info":[{"award-number":["No. 2023YXNS105"]}]},{"name":"The Key R&D Program of Jining","award":["No. 2023YXNS105"],"award-info":[{"award-number":["No. 2023YXNS105"]}]},{"name":"The Key R&D Program of Jining","award":["No. 2023YXNS105"],"award-info":[{"award-number":["No. 2023YXNS105"]}]},{"name":"The Key R&D Program of Jining","award":["No. 2023YXNS105"],"award-info":[{"award-number":["No. 2023YXNS105"]}]},{"name":"The Key R&D Program of Jining","award":["No. 2023YXNS105"],"award-info":[{"award-number":["No. 2023YXNS105"]}]},{"name":"The Key R&D Program of Jining","award":["No. 2023YXNS105"],"award-info":[{"award-number":["No. 2023YXNS105"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04086-8","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T08:32:32Z","timestamp":1742459552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acute neuromyelitis optica spectrum disorder patients\u2019 clinical analysis of disability-related biomarkers"],"prefix":"10.1186","volume":"25","author":[{"given":"Xingyue","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haotian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huakun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongrui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunbo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"2","key":"4086_CR1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177\u201389.","journal-title":"Neurology"},{"key":"4086_CR2","first-page":"100021","volume":"2","author":"DC Tian","year":"2020","unstructured":"Tian DC, Li Z, Yuan M, et al. Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: a national population-based study. Lancet Reg Health West Pac. 2020;2:100021.","journal-title":"Lancet Reg Health West Pac"},{"key":"4086_CR3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","volume":"11","author":"JY Hor","year":"2020","unstructured":"Hor JY, Asgari N, Nakashima I, et al. Epidemiology of Neuromyelitis Optica Spectrum Disorder and its Prevalence and Incidence Worldwide. Front Neurol. 2020;11:501.","journal-title":"Front Neurol"},{"issue":"3","key":"4086_CR4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/WCO.0000000000000328","volume":"29","author":"H Ochi","year":"2016","unstructured":"Ochi H, Fujihara K. Demyelinating diseases in Asia. Curr Opin Neurol. 2016;29(3):222\u20138.","journal-title":"Curr Opin Neurol"},{"issue":"10","key":"4086_CR5","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/cns.13904","volume":"28","author":"J Ding","year":"2022","unstructured":"Ding J, Jiang X, Cai Y, et al. Telitacicept following plasma exchange in the treatment of subjects with recurrent neuromyelitis optica spectrum disorders: a single-center, single-arm, open-label study. CNS Neurosci Ther. 2022;28(10):1613\u201323.","journal-title":"CNS Neurosci Ther"},{"issue":"10","key":"4086_CR6","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/jnnp-2014-308095","volume":"86","author":"S Masuda","year":"2015","unstructured":"Masuda S, Mori M, Arai K, et al. Epstein-Barr virus persistence and reactivation in neuromyelitis optica. J Neurol Neurosurg Psychiatry. 2015;86(10):1137\u201342.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4086_CR7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/2051-5960-2-48","volume":"2","author":"N Asavapanumas","year":"2014","unstructured":"Asavapanumas N, Verkman AS. Neuromyelitis Optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury. Acta Neuropathol Commun. 2014;2:48.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"4086_CR8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/bpa.12098","volume":"24","author":"M Bradl","year":"2014","unstructured":"Bradl M, Lassmann H. Experimental models of neuromyelitis optica. Brain Pathol. 2014;24(1):74\u201382.","journal-title":"Brain Pathol"},{"issue":"5","key":"4086_CR9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3174\/ajnr.A5141","volume":"38","author":"G Orman","year":"2017","unstructured":"Orman G, Wang KY, Pekcevik Y, et al. Enhancing brain lesions during Acute Optic Neuritis and\/or longitudinally extensive transverse myelitis may portend a higher relapse rate in Neuromyelitis Optica Spectrum Disorders. AJNR Am J Neuroradiol. 2017;38(5):949\u201353.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"4086_CR10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jnnp-2011-300434","volume":"83","author":"F Shimizu","year":"2012","unstructured":"Shimizu F, Sano Y, Takahashi T, et al. Sera from neuromyelitis optica patients disrupt the blood-brain barrier. J Neurol Neurosurg Psychiatry. 2012;83(3):288\u201397.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4086_CR11","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3389\/fneur.2018.00648","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang Y, Zhu M, Liu C, et al. Blood brain barrier permeability could be a biomarker to Predict Severity of Neuromyelitis Optica Spectrum Disorders: a retrospective analysis. Front Neurol. 2018;9:648.","journal-title":"Front Neurol"},{"key":"4086_CR12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clim.2016.06.017","volume":"189","author":"ER Pierson","year":"2018","unstructured":"Pierson ER, Wagner CA, Goverman JM. The contribution of neutrophils to CNS autoimmunity. Clin Immunol. 2018;189:23\u20138.","journal-title":"Clin Immunol"},{"issue":"2","key":"4086_CR13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.MIB.0000440614.83703.84","volume":"20","author":"SL Yan","year":"2014","unstructured":"Yan SL, Russell J, Granger DN. Platelet activation and platelet-leukocyte aggregation elicited in experimental colitis are mediated by interleukin-6. Inflamm Bowel Dis. 2014;20(2):353\u201362.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"4086_CR14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/ane.13401","volume":"143","author":"A Olsson","year":"2021","unstructured":"Olsson A, Gustavsen S, Gissel\u00f8 Lauridsen K, et al. Neutrophil-to-lymphocyte ratio and CRP as biomarkers in multiple sclerosis: a systematic review. Acta Neurol Scand. 2021;143(6):577\u201386.","journal-title":"Acta Neurol Scand"},{"key":"4086_CR15","doi-asserted-by":"crossref","first-page":"103514","DOI":"10.1016\/j.msard.2022.103514","volume":"58","author":"WC Huang","year":"2022","unstructured":"Huang WC, Lin HC, Yang YH, et al. Neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio are associated with a 2-year relapse in patients with multiple sclerosis. Mult Scler Relat Disord. 2022;58:103514.","journal-title":"Mult Scler Relat Disord"},{"key":"4086_CR16","doi-asserted-by":"crossref","unstructured":"Fu H, Qin B, Hu Z et al. Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis. Clin Lab. 2015. 61(3\u20134): 269\u2013\u200973.","DOI":"10.7754\/Clin.Lab.2014.140927"},{"issue":"2","key":"4086_CR17","doi-asserted-by":"crossref","first-page":"e0281064","DOI":"10.1371\/journal.pone.0281064","volume":"18","author":"M Cabanillas-Lazo","year":"2023","unstructured":"Cabanillas-Lazo M, Cruzalegui-Baz\u00e1n C, Pascual-Guevara M, et al. Clinical and immunologic significance of the neutrophil-to-lymphocyte ratio in neuromyelitis optica spectrum disorder: a systematic review with meta-analysis. PLoS ONE. 2023;18(2):e0281064.","journal-title":"PLoS ONE"},{"key":"4086_CR18","doi-asserted-by":"crossref","first-page":"628024","DOI":"10.3389\/fimmu.2021.628024","volume":"12","author":"E Carnero Contentti","year":"2021","unstructured":"Carnero Contentti E, Delgado-Garc\u00eda G, Criniti J, et al. An abnormally high neutrophil-to-lymphocyte ratio is not an independent outcome predictor in AQP4-IgG-Positive NMOSD. Front Immunol. 2021;12:628024.","journal-title":"Front Immunol"},{"key":"4086_CR19","doi-asserted-by":"crossref","first-page":"102345","DOI":"10.1016\/j.msard.2020.102345","volume":"45","author":"C Benetou","year":"2020","unstructured":"Benetou C, Berti F, Hemingway C, Hacohen Y, Lim M. Neutrophil-to-lymphocyte ratio correlates with disease activity in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in children. Mult Scler Relat Disord. 2020;45:102345.","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"4086_CR20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0009-8981(01)00573-3","volume":"310","author":"H Reiber","year":"2001","unstructured":"Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta. 2001;310(2):173\u201386.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"4086_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12967-019-02179-w","volume":"18","author":"LS de Araujo","year":"2020","unstructured":"de Araujo LS, Pessler K, S\u00fchs KW, et al. Phosphatidylcholine PC ae C44:6 in cerebrospinal fluid is a sensitive biomarker for bacterial meningitis. J Transl Med. 2020;18(1):9.","journal-title":"J Transl Med"},{"issue":"11","key":"4086_CR22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444\u201352.","journal-title":"Neurology"},{"issue":"1","key":"4086_CR23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00415-017-8676-8","volume":"265","author":"D Conradsson","year":"2018","unstructured":"Conradsson D, Ytterberg C, von Koch L, Johansson S. Changes in disability in people with multiple sclerosis: a 10-year prospective study. J Neurol. 2018;265(1):119\u201326.","journal-title":"J Neurol"},{"issue":"1","key":"4086_CR24","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1186\/s12913-017-2807-x","volume":"17","author":"A Sicras-Mainar","year":"2017","unstructured":"Sicras-Mainar A, Ru\u00edz-Beato E, Navarro-Artieda R, Maurino J. Impact on healthcare resource utilization of multiple sclerosis in Spain. BMC Health Serv Res. 2017;17(1):854.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"4086_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12987-020-00223-2","volume":"17","author":"S Meixensberger","year":"2020","unstructured":"Meixensberger S, Bechter K, Dersch R, et al. Sex difference in cerebrospinal fluid\/blood albumin quotients in patients with schizophreniform and affective psychosis. Fluids Barriers CNS. 2020;17(1):67.","journal-title":"Fluids Barriers CNS"},{"key":"4086_CR26","doi-asserted-by":"crossref","first-page":"101880","DOI":"10.1016\/j.msard.2019.101880","volume":"38","author":"B Chen","year":"2020","unstructured":"Chen B, Qin C, Tao R, et al. The clinical value of the albumin quotient in patients with neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2020;38:101880.","journal-title":"Mult Scler Relat Disord"},{"key":"4086_CR27","doi-asserted-by":"crossref","first-page":"104504","DOI":"10.1016\/j.msard.2023.104504","volume":"70","author":"C Yuan","year":"2023","unstructured":"Yuan C, Liu X, Cai S, et al. Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) is a promising predictor for the severity of acute AQP4-IgG positive neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2023;70:104504.","journal-title":"Mult Scler Relat Disord"},{"key":"4086_CR28","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.intimp.2019.105949","volume":"76","author":"L Ma","year":"2019","unstructured":"Ma L, Zeng A, Chen B, Chen Y, Zhou R. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with systemic lupus erythematosus and their correlation with activity: a meta-analysis. Int Immunopharmacol. 2019;76:105949.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"4086_CR29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3343\/alm.2019.39.4.345","volume":"39","author":"AY Gasparyan","year":"2019","unstructured":"Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The platelet-to-lymphocyte ratio as an inflammatory marker in Rheumatic diseases. Ann Lab Med. 2019;39(4):345\u201357.","journal-title":"Ann Lab Med"},{"key":"4086_CR30","doi-asserted-by":"crossref","first-page":"103507","DOI":"10.1016\/j.msard.2022.103507","volume":"58","author":"E Carnero Contentti","year":"2022","unstructured":"Carnero Contentti E, L\u00f3pez PA, Criniti J, et al. Platelet-to-lymphocyte ratio differs between MS and NMOSD at disease onset and predicts disability. Mult Scler Relat Disord. 2022;58:103507.","journal-title":"Mult Scler Relat Disord"},{"issue":"10","key":"4086_CR31","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/acn3.51167","volume":"7","author":"BL Chang","year":"2020","unstructured":"Chang BL, Ro LS, Chen CM, et al. Serum levels of cell adhesion molecules in patients with neuromyelitis optica spectrum disorder. Ann Clin Transl Neurol. 2020;7(10):1854\u201361.","journal-title":"Ann Clin Transl Neurol"},{"issue":"24","key":"4086_CR32","doi-asserted-by":"crossref","first-page":"e2105442","DOI":"10.1002\/advs.202105442","volume":"9","author":"Z Yu","year":"2022","unstructured":"Yu Z, Fang X, Liu W, et al. Microglia regulate blood-brain Barrier Integrity via MiR-126a-5p\/MMP9 Axis during Inflammatory Demyelination. Adv Sci (Weinh). 2022;9(24):e2105442.","journal-title":"Adv Sci (Weinh)"},{"key":"4086_CR33","doi-asserted-by":"crossref","first-page":"103527","DOI":"10.1016\/j.msard.2022.103527","volume":"59","author":"CC Fu","year":"2022","unstructured":"Fu CC, Gao C, Zhang HH, et al. Serum molecular biomarkers in neuromyelitis optica and multiple sclerosis. Mult Scler Relat Disord. 2022;59:103527.","journal-title":"Mult Scler Relat Disord"},{"issue":"6214","key":"4086_CR34","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1126\/science.1256478","volume":"346","author":"V Sreeramkumar","year":"2014","unstructured":"Sreeramkumar V, Adrover JM, Ballesteros I, et al. Neutrophils scan for activated platelets to initiate inflammation. Science. 2014;346(6214):1234\u20138.","journal-title":"Science"},{"key":"4086_CR35","doi-asserted-by":"crossref","first-page":"1097490","DOI":"10.3389\/fnins.2023.1097490","volume":"17","author":"X Fang","year":"2023","unstructured":"Fang X, Sun S, Yang T, Liu X. Predictive role of blood-based indicators in neuromyelitis optica spectrum disorders. Front Neurosci. 2023;17:1097490.","journal-title":"Front Neurosci"},{"issue":"2","key":"4086_CR36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10072-023-07058-3","volume":"45","author":"H Yan","year":"2024","unstructured":"Yan H, Wang Y, Li Y, et al. Combined platelet-to-lymphocyte ratio and blood-brain barrier biomarkers as indicators of disability in acute neuromyelitis optica spectrum disorder. Neurol Sci. 2024;45(2):709\u201318.","journal-title":"Neurol Sci"},{"issue":"7","key":"4086_CR37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jnen\/nly032","volume":"77","author":"D Sonia","year":"2018","unstructured":"Sonia D, Li Z, Luke Maxwell D, et al. Platelets drive inflammation and target Gray Matter and the retina in autoimmune-mediated encephalomyelitis. J Neuropathol Exp Neurol. 2018;77(7):567\u201376.","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04086-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04086-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04086-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T08:32:49Z","timestamp":1742459569000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04086-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4086"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04086-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Medical Ethics Committee of Jining No.1 People\u2019s Hospital (KYLL-202307-102), and written informed consent, including neurological consent, was obtained from all participants or their legal guardians. The research adhered to the principles outlined in the Helsinki Declaration and was conducted by approved guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}